Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Expanded Access Policy for Investigational Drugs
Healthcare Professionals
Investors & Media
Shares
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
Investors & Media Contact
Contact Us
Career
En
Sv
Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Expanded Access Policy for Investigational Drugs
Healthcare Professionals
Investors & Media
Shares
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
Investors & Media Contact
Contact Us
Career
Press releases
Prospectus relating to IBT’s rights issue published
April 27, 2016
To access the press release, please read the following disclaimer
here
.
Latest press releases
2026-03-03 07:00
Infant Bacterial Therapeutics (IBT) publishes results from ”The Connection Study” in Pediatric Research
2026-02-06 07:30
Infant Bacterial Therapeutics AB (publ) Year-end-report January 1 – December 31, 2025
Regulatory
2025-12-11 18:05
Infant Bacterial Therapeutics secures partnership with BioConnection for production of Drug Product
2025-11-25 18:41
IBT changes the IBP-9414 pathway for approval following discussions with the FDA
Regulatory
MAR
2025-11-20 16:42
Infant Bacterial Therapeutics AB secures partnership with Recipharm Advanced Bio for production of drug substance